{
  "url": "https://openlegislation.uk/medicines-exemption-from-licences-foods-and-cosmetics-amendment-order-1973/schedule/paragraph-2",
  "json_url": "https://openlegislation.uk/medicines-exemption-from-licences-foods-and-cosmetics-amendment-order-1973/schedule/paragraph-2.json",
  "legislation": "uksi/1973/2079",
  "legislation_title": "The Medicines (Exemption from Licences) (Foods and Cosmetics) Amendment Order 1973",
  "legislation_url": "https://openlegislation.uk/medicines-exemption-from-licences-foods-and-cosmetics-amendment-order-1973",
  "path": "schedule/paragraph/2",
  "kind": "paragraph",
  "number": "2",
  "heading": null,
  "text": "(1) Subject to the other provisions of this Article, the restrictions imposed by sections 7 and 8 of the Act (licences for dealings in and manufacture of medicinal products) shall not apply to anything done in relation to a medicinal product which is wholly or mainly for use by being administered to one or more human beings and which is or is to be for sale either for oral administration as a food or for external use as a cosmetic.\n(2) The exemption conferred by the preceding paragraph of this Article does not apply to a medicinal product as aforesaid which—\n(a) is or is to be sold with, accompanied by or having in relation to it, any particulars in writing specifying that product's curative or remedial function in relation to a disease specified or the use of that product for such curative or remedial purposes, or\n(b) being a product for oral administration as a food as aforesaid, comes within any of the descriptions contained in the Schedule to this order, or\n(c) being a product for external use as a cosmetic as aforesaid contains—\n(i) any antibiotic, or\n(ii) hexachlorophane, except where the product is exempted from the prohibition imposed by the Medicines (Hexachlorophane Prohibition) Order 1973(a) under paragraphs (2)(i)(a) or (2)(ii) of Article 2 of that order, or\n(iii) any hormone in a proportion (calculated on the weight of the medicinal product) in excess of 0.004 per cent. or\n(iv) resorcinol in a proportion (calculated as aforesaid) in excess of 1 per cent, or\n(d) being neither a vitamin preparation nor a substance coming within the description in paragraph 3 of the said Schedule, is or is to be sold with, accompanied by or having in relation to it any particulars in writing specifying the dosage relevant to that product's medicinal purpose.\n(3) Without prejudice to paragraph (2) of this Article, the exemption from section 7 of the Act (product licences) conferred by paragraph (1) of this Article does not apply to a medicinal product in respect of which there are, or are to be, directed to practitioners advertisements or representations of the nature and in the manner described in section 96(1) and (2) of the Act.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/1973/2079/schedule/paragraph/2",
    "retrieved_at": "2026-10-29T21:56:40.699070+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}